Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$670,888,028
+$207,571,370 QoQ
Shares Held
559,339
+11.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#117
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $1,983,048,474 across 16 Drug Manufacturers - General names. LLY ranks #1 (33.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
559,339 | $670,888,028 | |
| 2 | JNJ |
Johnson & Johnson
|
1,137,643 | $288,927,190 | |
| 3 | ABBV |
AbbVie Inc.
|
980,805 | $246,809,766 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,848,360 | $237,514,257 | |
| 5 | AMGN |
Amgen Inc
|
636,122 | $230,352,496 | |
| 6 | AZN |
Astrazeneca PLC
|
467,619 | $88,669,912 | |
| 7 | NVO |
Novo Nordisk A S
|
1,566,451 | $75,095,658 | |
| 8 | PFE |
Pfizer Inc
|
1,993,256 | $47,997,600 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,888,028 | 559,339 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $463,316,658 | 503,731 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $490,669,914 | 456,573 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $330,326,353 | 432,931 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $269,290,975 | 345,453 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $328,125,782 | 397,290 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $290,290,528 | 376,024 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $424,382,977 | 479,020 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $476,663,555 | 526,479 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $412,629,204 | 530,399 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $300,997,153 | 516,361 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $273,723,057 | 509,603 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $254,031,457 | 541,668 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $202,116,061 | 588,539 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $193,929,587 | 530,094 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $241,029,292 | 745,413 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $247,654,005 | 763,822 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $212,416,091 | 741,754 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $210,839,000 | 763,301 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $154,649,157 | 669,332 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $150,504,295 | 655,735 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $119,642,328 | 640,415 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $16,666,027 | 98,709 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,216,192 | 69,019 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,271,408 | 56,471 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $7,820,894 | 56,379 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||